Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on August 26, 2024. The filing serves to distribute a press release dated August 26, 2024, to U.S. investors pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide details regarding material changes versus prior comparable periods. The document consists solely of the cover page and exhibit index for the referenced press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. The content is limited to the formal submission of a press release (Exhibit 99.1) signed by CEO André Choulika.
Key Facts for Investor Verification
- Verify the full content of the press release dated August 26, 2024, referenced as Exhibit 99.1, as the summary text does not include its substance.
- Confirm the company's current cash position and runway, as no financial figures are present in this filing.
- Review the specific announcement made on August 26, 2024, to understand the catalyst for this regulatory filing.